TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel.

Rawan Faramand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.